ROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York--(Newsfile Corp. - June 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the 'Class Period'), of the important July 7, 2025 lead plaintiff deadline.
SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the West class action, go to https://rosenlegal.com/submit-form/?case_id=39367 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 7, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin High-Value Products ('HVP') portfolio; (2) West's SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to West's profit margins due to operational inefficiencies; (3) these margin pressures created the risk of costly restructuring activities, including West's exit from continuous glucose monitoring ('CGM') contracts with long-standing customers; and (4) as a result of the foregoing, defendants' positive statements about West's business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the West class action, go to https://rosenlegal.com/submit-form/?case_id=39367, call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/255496
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
35 minutes ago
- Business Wire
Lazard Welcomes Klaus H. Hessberger as Managing Director and Global Co-Head of Financial Sponsors Group
LONDON--(BUSINESS WIRE)--Lazard, Inc. (NYSE: LAZ) today announced that Klaus H. Hessberger has been appointed to the firm as Managing Director, Global Co-Head, and Head of Europe for Lazard's Financial Sponsors Group, based in London. Adam Cady, previously Lazard's Head of Large-Cap Financial Sponsor Coverage North America in New York, has also been named Global Co-Head of the Global Financial Sponsors Group, running the team together with Klaus. These appointments reflect Lazard's expanding connectivity and partnership with alternative asset managers, which continues to be a principal area of focus and a major source of future growth for the firm globally. Lazard's recruiting efforts are also a key contributor to the firm's long-term growth goals, with ongoing success in attracting top tier talent globally. 'Klaus is a recognised leader in the global financial sponsor community with an impressive track record of advising global alternative asset managers and leading teams of highly experienced industry professionals,' said Peter R. Orszag, CEO and Chairman. 'Together with Adam, who has played a pivotal role in managing Lazard's relationships with the world's largest alternative asset managers, we are well-positioned to further advance our market-leading offering to financial sponsor clients in Europe and globally.' 'I'm thrilled to join Lazard, a firm with a rich history and an unparalleled reputation for excellence in advising financial sponsor and corporate clients around the world. Lazard's leading global industry, sector and product platform and innovative approach ensure the firm's clients succeed in an increasingly complex investment landscape. Working alongside Adam and the talented team, I'm excited to build on Lazard's strong foundations and deliver meaningful results for our clients,' said Klaus H. Hessberger. Before joining Lazard, Klaus held various prominent roles over 25 years with J.P. Morgan, helping to build and co-running their market-leading European and later Global Financial Sponsors franchise, initially as European and later Global Co-Head. Klaus has most recently served as Vice Chair of the Global Financial Sponsors and Strategic Investors Coverage Group at J.P. Morgan. In these roles, Klaus covered top-tier global financial sponsor and strategic investor clients, including private equity and infrastructure funds, family offices, sovereign wealth and pension funds. In addition to his Financial Sponsor track record, Klaus brings a broad range of global industry sector and capital markets expertise, having previously co-run J.P. Morgan's Equity Capital Markets origination business in EMEA for nine years. Adam Cady has nearly three decades of experience in investment banking and capital markets. Prior to joining Lazard's New York office in February 2024, Adam held various senior positions at Bank of America, departing as Managing Director and Head of Americas Financial Sponsors Group. He started his career as a leveraged finance professional at Merrill Lynch and NationsBank. About Lazard Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit and follow Lazard on LinkedIn.
Miami Herald
an hour ago
- Miami Herald
China's Luckin Coffee opens first U.S. locations in New York City
July 1 (UPI) -- Starbucks got some heated competition Monday as China's largest coffee chain Luckin Coffee opened its first two locations in the United States. Luckin Coffee, which has more than 22,000 locations in China and Singapore, opened both U.S. stores in New York City, with one in Greenwich Village and the other in NoMad. No word on whether the Xiamen, China-based chain, plans to expand to more U.S. locations. Luckin, which was founded in 2017, features cashless payments and takeout booths for its coffee and other beverages that average about 30% cheaper than its competitor Starbucks. Within two years of serving up brew, Luckins overtook Starbucks in China. In New York City, Luckin may have to make some changes to comply with the city's cashless business ban, as well as U.S. coffee tastes. According to its website, it serves up single-origin espresso, signature lattes, matcha and fruity Americanos. The Chinese chain also touts its affordability and efficiency with a mobile app that is "completely changing the traditional coffee business mode." Luckin celebrated its venture into the United States on Monday with a $1.99 first drink for New Yorkers, who used the app, and a social media post with animated Luckin coffee cups as they take over dozens of New York yellow cabs. "NYC, you're luckin now," the company wrote. Copyright 2025 UPI News Corporation. All Rights Reserved.
Yahoo
an hour ago
- Yahoo
Ero Copper Expands Royal Gold Deal at Xavantina
Ero Copper Corp. (NYSE:ERO) is among the 11 Best Copper Stocks to Buy Now. It renewed its Precious Metals Purchase Agreement with Royal Gold with a $50 million Stream Supplement, bringing total proceeds to $160 million since 2021. A vast open-pit mine in a remote area, revealing the mining operations of the company. Ero Copper Corp. (NYSE:ERO) has extended Stage II gold delivery milestones at its Xavantina Operations in Brazil and broadened the stream's sphere of effect in return. It is anticipated that additional gold delivery under the Stream Supplement will start in 2028. Royal Gold will continue to receive 25% of the gold produced at 20% of the spot price under the revised terms, which apply to the first 49,000 ounces (Stage I), of which 45,177 ounces had been delivered by December 31, 2024. Royal Gold will get 25% of the gold at 40% of the spot price under stage II terms, which are in effect until 160,000 cumulative ounces are delivered. Stage III will generate 10% of production at 40% of the spot price for the life of the mine. Royal Gold's allocation is increased by 40,200 ounces by the Stream Supplement. The proceeds help Xavantina's long-term growth and 2025 capital expenditure plans. While we acknowledge the potential of ERO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None.
